And so it was. And is until 1q10 shows
Ebix is off to a good start to
realize that $ 1.15 profit for 2010(post split)
I switched proceeds from Ebix to PLX , which
moved as I estimated,but not as high as the 8%
after buying. The CEO of PLX will fly to
New York (the company is in Italy) to set out
their fabulus slide into biotech by way on
the common carrot, which forms somewhat
re-moleculized, the new plant basis
for amazing medications.The first one
(against rare Gautier Disease) has been given
a special protocol so it can be imported to
the US, at the chagrine of GENZ,(who sold
1.6 BILLION dollars of their anti-Gautier drug last year) until a nasty virus stopped their
production. Since Genz was the only making
a medication for Gautier, they had that
lucrative market until then.Meanwhile Genz
has cleaned up their mess,but PLX is making a nice splash with their drug (which is also
a lot cheaper)..It is all on the internet
so do your dd.
Interestingly, big boys from Pfizer came
to PLX plant for a look and see, which
started take over rumours..all this
will stand PLX in fine stead. And the
shares will continue to do well..
PLX price late Thursday $ 11.40